Home
>
US Stocks
>
Repare Therapeutics Inc
Repare Therapeutics Inc
RPTX

Repare Therapeutics Inc (RPTX)

$24.4525.84%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
22.3
Today Low/High
21.71 / 24.74
52 Week Low/High
$21.76 / $46.44
Market Cap
$1.27B

Company Details

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1/2 clinical development, as well as RP-6306, a CCNE1-SL inhibitor, and a Polθ inhibitor program.
Organisation
Repare Therapeutics Inc
Employees
102
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Repare Therapeutics Inc (RPTX) share price today?

Can Indians buy Repare Therapeutics Inc (RPTX) shares?

How can I buy Repare Therapeutics Inc (RPTX) shares from India?

Can Fractional shares of Repare Therapeutics Inc (RPTX) be purchased?

What are the documents required to start investing in Repare Therapeutics Inc (RPTX) stocks?

We are a SEBI registered investement advisor